The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients

Annals of Surgery

Volumn 251, Issue 6, 2010, Pages 1070-1078

  Rosenberg, Robert ^a   Engel, Jutta ^b,c   Bruns, Christiane ^c,d   Heitland, Wolfgang ^e   Hermes, Nikolaus ^f   Jauch, Karl Walter ^g   Kopp, Reinhard ^h   Pütterich, Eberhard ⁱ   Ruppert, Reinhard ^j   Schuster, Tibor ^a   Friess, Helmut ^a   Hölzel, Dieter ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Tumorregister   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f KLINIKUM BOGENHAUSEN   (Germany)

^g Klinikum Seefeld   (Germany)

^h Klinikum Harlaching   (Germany)

ⁱ Klinikum Dritter Orden   (Germany)

^j Institut für Pathologie   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; ARTICLE; CANCER GRADING; COLORECTAL CANCER; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; LYMPH NODE RATIO; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; SURVIVAL RATE; TUMOR CLASSIFICATION; TUMOR LOCALIZATION;

EID: 77953024250     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181d7789d     Document Type: Article

References (33)

1. Compton C, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:979-994.
2. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer; 2002.
3. Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583-596.
4. Chang GJ, Rodriguez-Bigas MA, Skibber JM, et al. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007;99:433-441.
5. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-463.
6. Wong SL, Ji H, Hollenbeck BK, et al. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149-2154.
7. Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219-225.
8. Simunovic M, Baxter NN. Lymph node counts in colon cancer surgery: lessons for users of quality indicators. JAMA. 2007;298:2194-2195.
9. Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706-8712.
10. Edler D, Ö hrling K, Hallström M, et al. The number of analyzed lymph nodes\a prognostic factor in colorectal cancer. Acta Oncol. 2007;46:975-981.
11. Lee HY, Choi HJ, Park KJ, et al. Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol. 2007;14:1712-1717.
12. Derwinger K, Carlsson G, Gustavsson B. A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol. 2008;34:771-775.
13. Schumacher P, Dineen S, Barnett C, et al. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg. 2007;194:827-832.
14. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, et al. Prognostic value of the lymph node ratio in node positive colon cancer. Gut. 2006;55:1681.
15. Wang J, Hassett J, Dayton MT, et al. Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol. 2008;15:1600-1608.
16. Frederique P, Stephane B, Catherine J, et al. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg. 2008;248:1067-1073.
17. Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio. A single-center analysis of 3026 patients over a 25-year time period. Ann Surg. 2008;248:968-978
18. Available at: http://www.destatis.de/jetspeed/portal/cms/Sites/destatis/ Internet/DE/Content/Statistiken/Bevoelkerung/GeburtenSterbefaelle/Tabellen/ Content100/SterbetafelDeutschland.psml.
19. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;38:933-942.
20. Park IJ, Choi GS, Jun SH. Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio. J Surg Oncol. 2009;100:240-243.
21. Vather R, Sammour T, Kahokehr A, et al. Lymph node evaluation and long-term survival in stage II and stage III colon cancer: a national study. Ann Surg Oncol. 2009;16:585-593.
22. Wang J, Kulaylat M, Rockette H, et al. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer? Ann Surg. 2009;249:559-563.
23. Kelder W, Inberg B, Schaapveld M, et al. Impact of the number of histolog-ically examined lymph nodes on prognosis in colon cancer: a population-based study in The Netherlands. Dis Colon Rectum. 2009;52:260-267.
24. Fleshman JW. Total number of lymph nodes as a quality of care measure for stage III colon cancer: is it reliable as a quality indicator? Ann Surg. 2009;249:564.
25. Doll D, Gertler R, Maak M, et al. Impact of reduced lymph node yield in patients with rectal carcinoma after neoadjuvant radiochemotherapy. World J Surg. 2009;33:340-347.
26. Bilimoria KY, Palis B, Stewart AK, et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008;51:154-161.
27. Johnson PM, Porter GA, Ricciardi R, et al. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570-3575.
28. Suzuki O, Sekishita Y, Shiono T, et al. Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer. J Am Coll Surg. 2006;202:732-736.
29. Friederichs J, Gertler R, Rosenberg R, et al. Prognostic impact of CK-20 positive cells in peripheral venous blood of patients with gastrointestinal carcinoma. World J Surg. 2005;29:422-428.
30. Riethdorf S, Wikman H, Pantel K. Review: biological relevance of disseminated tumor cells in cancer patients. Int J Cancer. 2008;123:1991-2006.
31. Vather R, Sammour T, Zargar-Shoshtari K, et al. Lymph node examination as a predictor of long-term outcome in Dukes B colon cancer. Int J Colorectal Dis. 2009;24:283-288.
32. Rosenberg R, Hoos A, Mueller J, et al. Prognostic significance of cytokera-tin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients. J Clin Oncol. 2002;20:1049-1055.
33. George S, Primrose J, Talbot R, et al. Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer. 2006;95:841-847.